100 Academy Way
Irvine, CA 92617
The UCI Sue & Bill Gross Stem Cell Research Center is proud to present Sally Temple PhD as the featured speaker of our 2019-20 Community Lecture Series. Dr. Temple is the Co-Founder and Scientific Director of the Neural Stem Cell Institute (NSCI) located in Rensselaer NY, USA. The mission of NSCI is to use stem cell research to create therapies for currently incurable disorders of the central nervous system – the brain, retina and spinal cord.
Using patient-derived induced pluripotent stem cells (iPSCs), Sally’s research group is building models to study neurodegenerative diseases, with the goal of identifying therapies. Sally helps lead the iPSC effort of the Tau Consortium, an international, collaborative group focused on understanding and developing therapies for dementias. Her group also models retinal degeneration using iPSC technology and collaborates with Dr. Jeff Stern and a team developing a cell therapy for age-related macular degeneration using an adult stem cell they discovered in the human retina.
Sally is past president of the International Society for Stem Cell Research (ISSCR), the largest global organization for scientists working in the stem cell field. Her work has been recognized with several awards, including the Jacob Javits and R35 awards from the National Institutes of Health, the MacArthur Fellowship, and the Ellison investigator award. Sally is the scientific cofounder of two biotech companies, StemCultures, which makes bioengineered growth factors for cell manufacture and Luxa Biotech, which is advancing the clinical trial for stem cell therapy patients with age-related macular degeneration.